TY  - GEN
AU  - Gartner, Silvia
AU  - Mondejar-Lopez, Pedro
AU  - Asensio de la Cruz, Oscar
AU  - Alonso, Maria Jose
AU  - Alvarez, Marina
AU  - Andres Martin, Anselmo
AU  - Barrio Gomez de Aguero, Maria Isabel
AU  - Cabero Perez, Maria Jesus
AU  - Caro Aguilera, Pilar
AU  - Cols Roig, Maria
AU  - Cortell Aznar-Perez, Isidoro
AU  - Costa Colomer, Jordi
AU  - Delgado-Pecellin, Isabel
AU  - Escribano Montaner, Amparo
AU  - Figuerola Mulet, Joan
AU  - Garcia Hernandez, Gloria
AU  - Guayarte, Pilar
AU  - Gil Ortega, David
AU  - Gomez Pastrana, David
AU  - Lamas Ferreiro, Adelaida
AU  - Marin Soria, Jose Luis
AU  - Martin de Vicente, Carlos
AU  - Navarro Merino, Martin
AU  - Oliva Hernandez, Concepcion
AU  - Perez-Frias, Javier
AU  - Perez Ruiz, Estela
AU  - Rovira Amigo, Sandra
AU  - Salcedo Posadas, Antonio
AU  - Sánchez-Solís, Manuel
AU  - Sirvent Gomez, Josep
AU  - Vazquez Cordero, Carlos
AU  - Villa Asensi, Jose Ramon
AU  - Soc Espanola Neumologia Pediat
PY  - 2019
DO  - 10.1016/j.anpedi.2018.11.009
SN  - 1695-4033
UR  - https://hdl.handle.net/20.500.12105/22684
AB  - Newborn screening (NBS) for cystic fibrosis (CF) is well-established in many countries and provides the opportunity for an early diagnosis and treatment before the development of irreversible structural lung damage. In 1999, Catalonia, Castilla-Leon,...
LA  - spa
PB  - Elsevier
KW  - Cystic fibrosis
KW  - Newborn screening
KW  - Guidelines for diagnosis and treatment
KW  - Aftercare
KW  - Infant, Newborn
KW  - Spain
KW  - Humans
KW  - Neonatal Screening
KW  - Cystic Fibrosis
KW  - Practice Guidelines as Topic
TI  - Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening
TY  - research article
ER  -